Cite
HARVARD Citation
Zeidman, L. et al. (n.d.). Clinical Features and Treatment Response in Immune-Mediated Small Fiber Neuropathy with Trisulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies. Journal of clinical neuromuscular disease. 22 (4), p. . [Online].